Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s EBIT?
- Mirum Pharmaceuticals, Inc. (MIRM) reported EBIT of -$42.54M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s EBIT changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s EBIT decreased by 752.6% year-over-year, from -$4.99M to -$42.54M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s EBIT has grown at a -40.2% compound annual growth rate (CAGR), from -$173.41M to -$22.14M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Mirum Pharmaceuticals, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude